PET imaging of primary mediastinal tumours

British Journal of Cancer

Volumn 73, Issue 7, 1996, Pages 882-886

  Kubota, K ^a   Yamada, S ^a   Kondo, T ^a   Yamada, K ^b   Fukuda, H ^a   Fujiwara, T ^a   Ito, M ^a   Ido, T ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Sendai Kosei Hospital   (Japan)

Author keywords

Mediastinal tumour; Positron emission tomography; Thymoma; 18F fluorodeoxyglucose

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; MALE; MEDIASTINUM TUMOR; MYELOMA; NEURILEMOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; THYMOMA; TUMOR DIAGNOSIS;

EID: 0029924606     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.157     Document Type: Article

References (44)

1. 99mTc sestamibi in tumor imaging. In Nuclear Medicine Annual 1994 Freeman LM (ed). Raven Press: New York, pp. 181-234.
2. ADLER LP, BLAIR HF, MAKLEY JT, WILLIAMS RP, JOYCE MJ, LEISURE G, AL-KAIST N AND MIRALDI F. (1991). Noninvasive grading of musculoskeletal tumors using PET. J. Nucl. Med., 32, 1508-1512.
3. ADLER LP, CROWE JP, AL-KAISI NK AND SUNSHINE JL. (1993). Evaluation of breast masses and axillary lymph nodes with [F-18]2-deoxy-2-fluoro-D-glucose PET. Radiology, 187, 743-750.
4. ARONBERG DJ, GLAZER HS AND SAGEL SS. (1985). MRI and CT of the mediastinum comparisons, controversies, and pitfalls. Radiol. Clin. North. Am., 23, 439-448.
5. BARES R, KLEVER P, HAUTMANN S, HELLWIG D, FASS J, CREMERIUS U, SCHUMPELICK V, MITTERMAYER C AND BÜLL U. (1994). F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology, 192, 79-86.
6. BROWN LR AND AUGHENBAUGH GL. (1991). Masses of the anterior mediastinum: CT and MR imaging. Am. J. Roentgenol., 157, 1171-1180.
7. BRUDIN LH, VALIND S-O, RHODES CG, PANTIN CF, SWEATMAN M. JONES T AND HUGHES JMB. (1994). Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur. J. Nucl. Med., 21, 297-305.
8. CHANDRAMOULY BS, SCAGNELLI T AND BURGESS C. (1989). Uptake of gallium in the mediastinum. Semin. Nucl. Med., 19, 247-249.
9. CHEN J, WEISBROD GL AND HERMAN SJ. (1988). Computed tomography and pathologic correlations of thymic lesions. J. Thorac. Imaging. 3, 61-65.
10. COHEN AJ, THOMPSON L, EDWARDS FH AND BELLAMY RF (1991). Primary cysts and tumors of the mediastinum. Ann. Thorac. Surg., 51, 378-386.
11. DAVIS JR RD, OLDHAM JR HN AND SABISTON JR DC. (1987). Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann. Thorac. Surg., 44, 229-237.
12. DEWAN NA, GUPTA NC, REDEPENNING LS, PHALEN JJ AND FRICK MP. (1993). Diagnostic efficacy of FDG-PET imaging in solitary pulmonary nodules. Chest, 104, 997-1002.
13. 18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest. Radiol., 22, 360-371.
14. FRONT D, ISRAEL O AND BEN-HAIM S. (1991). The dilemma of a residual mass in treated lymphoma: The role of callium-67 scintigraphy. In Nuclear Medicine Annual 1991, Freeman LM (ed) Raven Press: New York. pp. 211-220.
15. GRAEBER GM, SHRIVER CD, ALBUS RA, BURTON NA, COLLINS GJ, LOUGH FC AND ZAJTCHUK R. (1986). The use of computed tomography in the evaluation of mediastinal masses. J. Thorac. Cardiovasc. Surg., 91, 662-666.
16. HABERKORN U, ZIEGLER SI, OBERDORFER F, TROJAN H, HAAG D, PESCHKE P, BERGER MR, ALTMANN A AND VAN KAICK G. (1994). FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl. Med. Biol., 21, 827-834.
17. HERHOLZ K, PIETRZYK U, VAGES J, SCHRÖDER R, HALBER M, TREUER H, STURM V AND HEISS W-D (1993). Correlation of glucose consumption and tumor cell density in astrocytomas. J. Neurosurg., 79, 853-858.
18. HIGASHI K, CLAVO AC AND WAHL RL. (1993). Does FDG uptake measure proliferative activity of human cancer cells? In vivo comparison with DNA flow cytometry and tritiated thymidine uptake. J. Nucl. Med., 34, 414-419.
19. KUBOTA K, MATSUZAWA T, ITO M, FUJIWARA T, ABE Y, YOSHIOKA S, FUKUDA H, HATAZAWA J, IWATA R, WATANUKI S AND ITO T. (1985). Lung tumor imaging by positron emission tomography using C-11 L-methionine. J. Nucl. Med., 26, 37-42.
20. KUBOTA K, MATSUZAWA T, FUJIWARA T, ITO M, HATAZAWA J, ISHIWATA K, IWATA R AND IDO T. (1990). Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J. Nucl. Med., 31, 1927-1933.
21. KUBOTA R, YAMADA S, KUBOTA K, ISHIWATA K, TAMAHASHI N AND IDO T. (1992). Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med., 33, 1972-1980.
22. KUBOTA K, KUBOTA R AND YAMADA S (1993). FDG accumulation in tumor tissue. J. Nucl. Med., 34, 419-421.
23. KUBOTA R, KUBOTA K, YAMADA S, TADA M, IDO T AND TAMAHASHI N. (1994). Active and passive mechanisms of [fluorine-18]fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J. Nucl. Med., 35, 1067-1075.
24. KUBOTA R, KUBOTA K, YAMADA S, TADA M, TAKAHASHI T, IWATA R AND TAMAHASHI N. (1995). Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J. Nucl. Med., 36, 484-492.
25. LANGEN KJ, BRAUN U, KOPS R, HERZOG H, KUWERT T, NEBELING B AND FEINENDEGEN LE. (1993). The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J. Nucl. Med., 34, 355-359.
26. 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br. J. Cancer, 64, 1121-1124.
27. LESKINEN-KALLIO S, NÅGREN K, LEHIKOINEN P, RUOTSALAINEN U, TERAS M AND JOENSUU H. (1992). Carbon-11-methionine and PET is an effective method to image head and neck cancer. J. Nucl. Med., 33, 691-695.
28. LEWIS JE, WICK MR, SCHEITHAUER BW, BERNATZ PE AND TAYLOR WF. (1987). Thymoma: a clinicopathologic review. Cancer, 60, 2727-2743.
29. LEWIS PJ AND SALAMA A. (1994). Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J. Nucl. Med., 35, 1647-1649.
30. LINDHOLM P, MINN H, LESKINEN-KALLIO S, BERGMAN J, RUOTSALAINEN U AND JOENSUU H. (1993). Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J. Nucl. Med., 34, 1-6.
31. LINK KM, SAMUELS LJ, REED JC, LOEHR SP AND LESKO NM. (1993). Magnetic resonance imaging of the mediastinum. J. Throrac. Imaging, 8, 34-53.
32. MAZZIOTA JC, PHELPS ME, PLUMMER D AND KUHL DE. (1981). Quantitation in positron emission computed tomography: 5 Physical-anatomical effects. J. Comput. Assist. Tomogr., 5, 734-743.
33. MINN H, JOENSUU H, AHONEN A AND KLEMI P. (1988). Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer. 61, 1776-1781.
34. OKAZUMI S, ISONO K, ENOMOTO K, KIKUCHI T, OZAKI M, YAMAMOTO H, HAYASHI H, ASANO T AND RYU M. (1992). Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterisation of tumor and assessment of effect of treatment. J. Nucl. Med., 33, 333-339.
35. PATRONAS NJ, DI CHIRO G, KUFTA C, BAIRAMIAN D, KORNBLITH PL, SIMON R AND LARSON SM (1985). Prediction of survival in glioma patients by means of positron emission tomography. J. Neurosurg., 62, 816-822.
36. PATZ EF, LOWE VJ, HOFFMAN JM, PAINE S, BURROWES P. COLEMAN RE AND GOODMAN PC. (1993). Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology, 188, 487-490.
37. REBNER M, GROSS BH, ROBERTSON JM, PENNES DR, SPIZARNY DL AND GLAZER GM (1987). CT evaluation of mediastinal masses. Comput. Radiol., 11, 103-110.
38. RENDINA EA, VENUTA F, CERONI L, MARTELLI M, GUALDI G, CATERING M AND RICCI C (1988). Computed tomographic staging of anterior mediastinal neoplasms. Thorax, 43, 441-445.
39. STRAUSS LG AND CONTI PS. (1991). The application of PET in clinical oncology. J. Nucl. Med., 32, 623-648.
40. TONAMI N, YOKOYAMA M, TAKI J, SHUKE N, MIYAUCHI T, MICHIGISHI T, ABURANO T AND HISADA K. (1993). Detection of thymic abnormality in myasthenia gravis with thallium-201 SPECT. J. Nucl. Med., 34, 223p.
41. TSAN MF AND SCHEFFEL U. (1986). Mechanism of gallium-67 accumulation in tumours. J. Nucl. Med., 27, 1215-1219.
42. WAHL RL, CODY RL, HUTCHINS GD AND MUDGETT EE. (1991). Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabelled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 179, 765-770.
43. 18F]fluoro-D-glucose in human cancer heterotransplanted in nude mice: comparison between histology and glycolytic status. J. Nucl. Med., 35, 97-103.
44. ZASADNY KR AND WAHL RL. (1993). Standardised uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology, 189, 847-850.